Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Harvard Bioscience Announces First Quarter 2026 Financial Results
-
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
-
Aging Renters Emerge as a Strategic Growth Opportunity for Insurance Providers, New TransUnion Report Finds
-
POET Technologies Announces Appointment of Sandeep Kumar as Chief Operating Officer
-
OVIOS x Studio F. A. Porsche Debuts AERO EVO on the Nasdaq Tower in Times Square
-
Hub Group Files Form 12b-25 and Provides First Quarter 2026 Business Update
-
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
-
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
-
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth
-
CorVel Corporation to Host Live Earnings Release Webcast
-
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
-
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
-
Creative Realities, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
-
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Bitdeer Announces April 2026 Production and Operations Update
-
Parex Resources Positioned to Become Colombia’s Largest Independent Oil & Gas Producer, Provides Step-Change Guidance, Reports Q1 2026 Results, and Declares Q2 2026 Dividend
-
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
-
George Weston Limited Reports First Quarter 2026 Results
-
MADD Canada Calls for Anti-Impaired Driving Technology as Global Safety Leaders Meet in Toronto
-
Mediacom Advances Its DOCSIS 4.0 Network Upgrades Plans With AOI Quantum Bandwidth
-
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
-
American Bus Association Sues New York City Over Discriminatory Idling Enforcement That Threatens Interstate Transportation and the City’s Economy
-
Legacy Cremation Services Brazenly Violating Federal Court Order
-
NexGold Initiates VTEM™ and FALCON® Gravity Airborne Geophysical Surveys at Goldboro and Announces Appointment of New Board Member
-
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
-
Lantronix xPico 600 Brings Wi-Fi 6, Enterprise Security and Cloud Management to Industrial IoT — All in a Single Embedded Module
-
Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases
-
SOLV Energy Reports First Quarter 2026 Results
-
Yukon Metals Expands Porphyry Portfolio With New Northern BC Property Near Yukon Border
-
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
-
Amplify ETFs Files for Amplify Fairlead Tactical Bitcoin ETF
-
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
-
HeyNews Launches Voice-Trained AI Newsletter Platform After Producing Nearly 600 Internal Issues
-
Cal-Maine Foods and Sara Lee Frozen Bakery Announce Cal-Maine Foods’ Acquisition of Van’s Foods Brand, Advancing Cal-Maine Foods’ Diversification Strategy and Expanding Consumer-Facing Retail Pr
-
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
-
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
-
Beamr to Demonstrate Video Data Processing for Resilient AV Models at Smart Mobility Summit
-
Immatics Announces First Quarter 2026 Financial Results and Business Update
-
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
-
Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections
-
ProQR Announces First Quarter 2026 Operating and Financial Results
-
eToro Reports First Quarter 2026 Results
-
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
-
Felix Health to Lower Semaglutide Pricing by Up to 65% as Lower-Cost Options Enter Canada
-
Loblaw Releases 2025 Live Life Well® Report Highlighting Progress in Sustainability, Community Support, and Social Impact
-
American Battery Materials Provides Operational Update on Lisbon Valley Development Evaluation
-
OTC Markets Group Welcomes Silver X Mining Corp. to OTCQX
-
Sionna Therapeutics Reports First Quarter 2026 Financial Results

